All Updates

All Updates

icon
Filter
Partnerships
Antiverse collaborates with a top-20 pharma company for antibody drug discovery
AI Drug Discovery
Jan 31, 2022
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Jan 31, 2022

Antiverse collaborates with a top-20 pharma company for antibody drug discovery

Partnerships

  • UK-based AI biotechnology company Antiverse has entered into a partnership with a top-20 pharmaceutical company (name undisclosed) to jointly discover novel antibody drug candidates. The terms and financial details of the agreement have not been disclosed. 

  • The collaboration has already been successful in identifying candidates for specific drug targets with 2.3x greater diversity and accuracy, by leveraging Antiverse’s AI-powered antibody drug discovery platform that has identified 248 sequences, of which 230 have been antibody binders and five have been cross-reactive.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.